General
-
Headquarters
San Francisco, California, United States
-
Founders & Team
Glenn Markov, John Ramunas
-
Year Founded
2016
-
Company type
Private company
-
Funding stage
Seed
-
Investors
Y Combinator
Technical Details
-
Aging Target
Telomere attrition
-
Disease indication
NASH, Alcoholic Hepatitis, Acute Liver Failure, Idiopathic Pulmonary Fibrosis, Cytopenia, Bone Marrow Transplat, Dyskeratosis congenita
-
Product modality
nucleoside-modified TERT mRNA
-
Clinical stage
Pre-clinical
About
Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.
Pipeline
